Prof. Mark Post
Professor Mark Post is an MD, PhD and chair of the Physiology Department at Maastricht University. His main research interest is the engineering of tissues for medical applications and for food, which has lead to the development of cultured beef from bovine skeletal muscle stem cells in an effort to supplement and transform the traditional meat production through livestock. In August 2013, he presented the world’s first hamburger from cultured beef. He is CSO and co-founder of two companies, MosaMeat and Qorium that will commercialize cultured meat and cultured leather.
Prof. Shulamit Levenberg
Faculty of Biomedical Engineering, Technion
Prof. Levenberg conducts interdisciplinary research on stem cells and tissue engineering. She did her post doctorate research on tissue engineering with Prof. Robert Langer at MIT and joined the Technion Biomedical Engineering department on 2004. During 2011-2012 she spent her sabbatical year as a visiting professor at the Wyss institute for Biology inspired Engineering at Harvard. In her research she studies vascularization of engineered tissues with a focus on inducing vessel network formation in engineered 3D skeletal muscle tissue constructs. She is also developing micro bioreactors and nanoliter droplet devices for cell growth and manipulations. Levenberg received the Krill Prize for excellence in scientific research by the Wolf Foundation, and was named by Scientific American as a “Research Leader” in Tissue Engineering for her studies on vascularization of engineered tissues. Prof. Levenberg is currently the elected Dean of the Biomedical Engineering Department at the Technion and a member in the Israel National Bioethics committee.
Prof. Smadar Cohen
Claire and Harold Oshry Professor Chair in Biotechnology at the Ben Gurion University in the Negev
Founder, The Avram and Stella Goldstein-Goren Department of Biotechnology Engineering Founder and Director, The Regenerative Medicine and Stem Cell (RMSC) Research Center
Professor Cohen's research focusses on the advancement and development of critical research tools for promoting tissue engineering and regenerative medicine. Her research includes: 1) the design of bio-inspired materials for tissue regeneration and engineering (including as defined stem cell microenvironment), 2) the development of advanced perfusion bioreactors, with mechanical and electrical stimulation for ex-vivo cell cultivation and tissue engineering; and 3) implementation of intelligent nano-sized delivery systems for therapeutics.
Cohen received prizes as the Landau Prize of Mifal HaPayis (2016), The Rappaport Prize in Biomedical Research (2010), The Teva Founders Award (2009), The Juludan Prize for Biomedical Research (2002). She was invited to give over 150 lectures and seminars and chaired 50 sessions. Cohen is the author of over 120 papers in referred Journals, co-authored a book on Cardiac Tissue Engineering and edited two books.
She serves as the Associate Editor of the Journal Annals in Biomedical Engineering, is an Executive Board Member of Tissue Engineering A, B,C and on the Editorial Board of the Biomatter. Cohen invented 40 issued and pending US patents. She is on the Scientific Advisory Board of several bio-nano-technology companies and serves as a member of the Magnet Committee of the Israel Ministry of Economics. Professor Cohen supervised over 70 students; Ten are faculty members in Israeli and US universities and colleges.
Prof. Eyal Shimoni
Strauss Group, CTO & VP Technology
Prof. Eyal Shimoni is one of Israel's top food engineering & technology experts, with vast academic and industrial experience. He serves as the CTO, VP Technology of Strauss Group (http://www.strauss-group.com/?en=1) as of 2010.
He is in charge of the Technological strategy for the group, as well identifying, evaluating, and developing innovative technologies with Alpha-Strauss, the Food Tech Community (www.alphastrauss.com). Currently he is also a board member of the newly established FoodTech incubator in Israel, "The Kitchen" by Strauss.
He is a world renowned researcher in food science and technology, with global network in these fields. To date he published over 70 peer reviewed scientific papers, book chapters and patents. Eyal is a proud Technion graduate (BSc, MSc, DSc) (http://www.technion.ac.il/en/), with a post doc in the university of Minnesota.
He was a research professor in the Department of Biotechnology and Food Engineering of the Technion 2000-2013, with projects with industrial partners, as well as basic research, mostly in food biophysics and food nanoscience. Over the years he consulted to numerous companies, and led various tech transfer projects.
Dr. Liz Specht
The Good Food Institute, USA
Liz is a Senior Scientist with the Good Food Institute, a non-profit organization whose mission is to advance plant-based and cell cultured food technology to render animal agriculture obsolete. Liz has a bachelor’s degree in chemical and biomolecular engineering from Johns Hopkins University, a doctorate in biological sciences from the University of California, San Diego, and postdoctoral research experience from the University of Colorado, Boulder. At GFI, Liz works to identify and address areas of need for plant-based and cell culture-based scientific innovation and she works with academic researchers, grant funding agencies, entrepreneurs, and venture capital firms to prioritize work that advances this field.
Mr. Sasha Mandy
Sasha Mandy is a lawyer and patent agent working in Intellectual Property (IP) law at the global law firm Norton Rose Fulbright.
He has a keen interest in the field of cellular agriculture, and clean meat in particular.
Sasha has presented on the IP issues facing stakeholders in clean meat and cellular agriculture, and solutions to emerging problems in the field.
He most recently presented at the 2nd International Conference on Cultured Meat in Maastricht, Netherlands in October, 2016.
Norton Rose Fulbright is becoming a global thought leader on cellular agriculture, and is developing expertise in this emerging technical field to assist clients on a wide range of issues they may encounter.
Prof. Yaakkov "Koby" Nahmias
Chair, Department of Bioengineering
The Hebrew University of Jerusalem
Prof. Yaakov “Koby” Nahmias received his B.Sc. from the Technion, Israel Institute of Technology, Magna Cum Laude. He did his PhD at the University of Minnesota and his postdoctoral training at Massachusetts General Hospital. In 2006, he became a faculty member of Harvard Medical School, winning a prestigious National Institute of Health (NIH) Career Award. In 2009, Prof. Nahmias moved to the Hebrew University of Jerusalem, where he won European Research Council (ERC) starting and consolidator grants, and the prestigious Rappaport Prize for Biomedical Sciences. He authored over 50 peer-reviewed papers, and a book titled Microdevices in Biology and Medicine. He is a recognized expert in liver biology and metabolism whose work is published in the leading journals of the field including the PNAS, Cell Metabolism, Nature Medicine, and Nature Biotechnology. Prof. Nahmias is the head of the microLiver Technologies (μLT) Laboratory, and a member of the ERC Biotechnology Panel (LS9). As of 2010 he is serving as the Founding Director of the Alexander Grass Center of Bioengineering and the BioDesign: Medical Innovation program at the Hebrew University of Jerusalem.
Prof. Yoav Livney
Faculty of Biotechnology and Food Engineering, Technion.
Head, Lab of Food Physical Chemistry & Biopolymeric delivery systems for health.
Prof. Yoav D. Livney is a member of the Faculty of Biotechnology and Food Engineering at the Technion, IIT. He is an expert in physical chemistry of biopolymers. Prof. Livney holds a PhD and a B.Sc. (Suma Cum Laude) in Food Engineering & Biotechnology from the Technion, and a M.S. in Food Engineering from the university of Wisconsin, Madison, Wisconsin, USA. His research focusses on the development of novel nano-delivery systems for nutraceuticals and drugs, and on the extraction of food biopolymers form new and renewable raw materials.
Livney is the coordinator of the Technion activities within the European Consortium “EIT Food”.
Dr. Ohad Karnieli
Atvio Biotech, CEO & Co-Founder
Dr. Karnieli earned his PhD in Biotechnology focusing on Cell & Gene Therapy from the Sacler school of Medicine at Tel Aviv University and an MBA from the Haifa University school of management. Dr. Karnieli served in several executive rolls in the field of cell therapy and medical devices with his last position being the VP of Technology & Manufacturing at Pluristem Therapeutics. A well-known expert in the field of cell therapy process development and serves on several industry committees including chairing of the process & product development committee of the International Society for Cell Therapy and an expert member in the ISO TC276 Bioprocessing committee. Dr. Karnieli is the founder of Karnieli Ltd and ADVA Biotechnology.
Mr. Amir Zaidman
The Kitchen FoodTech Hub, VP Business Development
Amir Zaidman has more than 15 years of experience in business development and early stage investments in several technology sectors.
Mr. Zaidman is the vice-president of business development of "The Kitchen" the first and only Israeli technology incubator focusing on FoodTech.
In addition to deal-sourcing and evaluating new investment opportunities, he provides biz-dev support to the portfolio companies.
Amir also takes an active role in promoting a FoodTech community in Israel. Hemanages the Israel FoodTech Innovation LinkedIn group (currently ~950 members and growing daily), as well as a MeetUp group that holds 6-8 events annually for FoodTech entrepreneurs.
Prior to joining the Kitchen founding team, Mr. Zaidman held several executive business development positions in the Innovation and Tech sectors including: VP at RDC (Rafael Development Corp.); VP Commercial Affairs at BGN (BenGurion University’s tech transfer) and Principal at 7 Health Ventures (a medtech focused VC).
Dr. Yaron Bogin
The Modern Agriculture Foundation, CEO
Dr. Bogin is an experienced professional in research, development and commercialization of innovative bio-technologies. Dr. Bogin served as a stem cell technologies development manager at Accellta, and as an R&D manager at the Alfred Mann Institute at the Technion (AMIT). He holds a PhD in Cell Biology from the Technion, B.Sc. in Life Sciences from Tel Aviv University and B.A in Psychology and East Asian Studies from the Hebrew University in Jerusalem.
Mr. Itay Beck
Israel Innovation Authority, Director of the Technological Incubators Program in the Startup Division
Mr. Itay Beck currently serves as the Director of the Technological Incubators Program in the Startup Division of the Israel Innovation Authority.
For the past 20 years, Mr. Beck has held various executive, consultancy and operational positions, in both the government and in the private sector, focusing on development of innovative technological startups and service industries.
Mr. Beck holds a BA in Economics and International Relations, and an MBA in Technology, Innovation and Entrepreneurship Management.
Dr. Michal Amit
Accellta, CEO & CTO
A Doctor of science in Medicine and a Senior lecturer at the Ephraim Katzir Department of Biotechnology Braude College .
Michal Amit has more than 20 years of research and teaching experience in the field of stem cells. Michal’s research focuses on the development of suspension culture techniques and medium formulations for the mass production and directed differentiation of pluripotent stem cells.
She published more than 30 research articles and submitted more than 10 patents. Michal led (NIH-funded) international courses regarding pluripotent stem cells culture technique at the John Hopkines University at Baltimor, USA.
In 2012 she founded a start-up company, Accellta, based on her novel technologies for mass culturing of stem cells.
Mr. Bruce Friedrich
The Good Food Institute, Executive Director
Bruce graduated magna cum laude from Georgetown Law and Phi Beta Kappa from Grinnell College and also holds degrees from Johns Hopkins University and the London School of Economics. Bruce has held leadership roles for the past two decades at top nonprofits working to reform animal agriculture. Bruce is a popular speaker on college campuses and has presented repeatedly at most of the nation's top universities, including Harvard, Yale, Princeton, Stanford, and MIT. Bruce co-authored one book, contributed chapters to five books, and authored six law review articles. Bruce is co-trustee of New Crop Capital, a venture capital fund that invests in plant-based and "clean meat" companies (NewCropCapital.com). Recent publications, presentations, and interviews: https://works.bepress.com/bruce_friedrich/
Mr. Paul Shapiro
The Humane Society of the United States, Vice President of Policy
Paul Shapiro focuses on promoting policies that advance animals‘ interests across all 50 states.
From 2005–2016 he served as the head of HSUS‘s farm animal protection efforts, where he played an integral role in numerous successful legislative and corporate campaigns to improve the plight of farm animals.
Shapiro founded Compassion Over Killing in 1995 and served as its Campaigns Director until January 2005. While there, he worked as a farm animal cruelty investigator and led initiatives to end misleading advertising on factory farm products.
Shapiro has been interviewed in hundreds of print, broadcast and online news sources as an authority on animal welfare and advocacy. He has also published dozens of articles about animal welfare in publications ranging from daily newspapers to academic journals.
Shapiro is also the author of a forthcoming book on the clean meat movement (due out Fall 2017, Regan Arts).
Prof. Amit Gefen
Professor in Biomedical Engineering, Tel Aviv University
Prof. Amit Gefen received the B.Sc. in Mechanical Engineering and M.Sc. and Ph.D. in Biomedical Engineering from Tel Aviv University in 1994, 1997, and 2001, respectively. During 2002-2003 he was a post-doctoral fellow at the University of Pennsylvania, USA. He is currently a Full Professor with the Department of Biomedical Engineering at the Faculty of Engineering of Tel Aviv University. The research interests of Prof. Gefen are in studying normal and pathological effects of biomechanical factors on the structure and function of cells, tissues and organs. In 2007-2008 he was a visiting scientist at Eindhoven University of
Technology in the Netherlands, where he developed tissue-engineered model systems of skeletal muscle. To date, Prof. Gefen published more than 190 articles in peer-reviewed international journals, many of which on mechanobiology, cell and tissue engineering, with applications that are mostly in injury prevention. He is the Editor-in- Chief of Clinical Biomechanics (published by Elsevier) and a book series on Mechanobiology, Tissue Engineering and Biomaterials (published by Springer). Prof. Gefen is a member of the World Council of Biomechanics and a Fellow of the International Academy of Medical and Biological Engineering and the European Alliance for Medical and Biological Engineering. His research is funded for example by the Israel Science Foundation, Israeli Ministry of Health, Ministry of Science, Ministry of Defense, and national and international biomedical industries. He also serves as the Chair of Scientific Advisory Boards of large international corporates.